Randomized Study of Human Parathyroid Hormone in Middle-Aged Men With Idiopathic Osteoporosis
Recruitment status was Recruiting
I. Determine the effect of human parathyroid hormone (1-34) on bone mass in middle-aged men with idiopathic osteoporosis.
|Study Design:||Allocation: Randomized
Primary Purpose: Treatment
|Study Start Date:||October 1999|
PROTOCOL OUTLINE: This is a randomized, double blind, placebo controlled study. All patients self-administer daily subcutaneous injections of human parathyroid hormone (1-34) or placebo for a period of 2.5 years.
Patients are followed regularly for unacceptable toxicities.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00004406
|United States, New York|
|Columbia University College of Physicians and Surgeons||Recruiting|
|New York, New York, United States, 10032|
|Contact: John Paul Bilezikian 212-305-6238|
|Study Chair:||John Paul Bilezikian||Columbia University|